Assessment of Molecular Relapse Detection in Early-Stage Breast CancerIsaac García-Murillas, Nicholas C. Turner, Giselle Walsh-Crestani et al.|JAMA Oncology|2019Cited by 425
BioMart Central Portal: an open database network for the biological communityJonathan M. Guberman, Kevin Stone, Jing Ai et al.|Database|2011Cited by 170
Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy ResistanceAlex Pearson, Nicholas C. Turner, Paula Proszek et al.|Clinical Cancer Research|2019Cited by 137
Genomic profile of advanced breast cancer in circulating tumour DNABelinda Kingston, Nicholas C. Turner, Rosalind Cutts et al.|Nature Communications|2021Cited by 95
Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in <i>PIK3CA</i> -Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid CancersJavier Pascual, Nicholas C. Turner, Joline S.J. Lim et al.|Cancer Discovery|2020Cited by 67